Bone and metabolic markers in women with recurrent calcium stones

Korean Journal of Urology

Volumn 54, Issue 3, 2013, Pages 177-182

  Arrabal Polo, Miguel Angel ^a   Arrabal Martin, Miguel ^a   Arias Santiago, Salvador ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

Bone density; Calcium; Urolithiasis; Women

Indexed keywords

PARATHYROID HORMONE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; BONE DENSITOMETRY; BONE DENSITY; BONE METABOLISM; CALCIUM BLOOD LEVEL; CALCIUM STONE; CALCIUM URINE LEVEL; CHEMICAL ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NEPHROLITHIASIS; RECURRENT DISEASE; URINALYSIS;

EID: 84875281088     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2013.54.3.177     Document Type: Article

References (23)

1. Lancina Martin JA, Rodriguez-Rivera Garcia J, Novas Castro S, Rodriguez Gomez I, Fernandez Rosado E, Alvarez Castelo L, et al. Metabolic risk factors in calcium urolithiasis according to gender and age of the patients. Actas Urol Esp 2002;26:111-20.
2. Yagisawa T, Hayashi T, Yoshida A, Kobayashi C, Okuda H, Ishikawa N, et al. Comparison of metabolic risk factors in patients with recurrent urolithiasis stratified according to age and gender. Eur Urol 2000;38:297-301.
3. Konstantinova OV, Ianenko EK, Dzeranov NK. Recurrence-free and recurrent urolithiasis: metabolic differences. Urologiia 1999;(5):8-9.
4. Menditto VG, Milanese G, Muzzonigro G. Metaphylaxis of urolithiasis. Arch Ital Urol Androl 2009;81:32-9.
5. Caudarella R, Vescini F, Buffa A, La Manna G, Stefoni S. Osteoporosis and urolithiasis. Urol Int 2004;72 Suppl 1:17-9.
6. Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ 3rd, Khaltaev N. A reference standard for the description of osteoporosis. Bone 2008;42:467-75.
7. Arrabal-Polo MA, Arrabal-Martin M, de Haro-Munoz T, Poyatos-Andujar A, Palæo-Yago F, Zuluaga-Gomez A. Biochemical determinants of severe lithogenic activity in patients with idiopathic calcium nephrolithiasis. Urology 2012;79:48-54.
8. Amaro CR, Goldberg J, Amaro JL, Padovani CR. Metabolic assessment in patients with urinary lithiasis. Int Braz J Urol 2005;31:29-33.
9. Marangella M, Vitale C, Bagnis C, Bruno M, Ramello A. Idiopathic calcium nephrolithiasis. Nephron 1999;81 Suppl 1:38-44.
10. Areses Trapote R, Urbieta Garagorri MA, Ubetagoyena Arrieta M, Mingo Monge T, Arruebarrena Lizarraga D. Evaluation of renal stone disease: metabolic study. An Pediatr (Barc) 2004;61: 418-27.
11. Spivacow FR, del Valle EE, Zancheta JR. Renal lithiasis. Biochemical changes in the follow-up. Medicina (B Aires) 2006;66:201-5.
12. Vella M, Karydi M, Coraci G, Oriti R, Melloni D. Pathophysiology and clinical aspects of urinary lithiasis. Urol Int 2007;79 Suppl 1:26-31.
13. Caudarella R, Vescini F, Buffa A, Sinicropi G, Rizzoli E, La Manna G, et al. Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors. J Nephrol 2003;16:260-6.
14. Tsuji H, Umekawa T, Kurita T, Uemura H, Iguchi M, Kin K, et al. Analysis of bone mineral density in urolithiasis patients. Int J Urol 2005;12:335-9.
15. Giannini S, Nobile M, Dalle Carbonare L, Lodetti MG, Sella S, Vittadello G, et al. Hypercalciuria is a common and important finding in postmenopausal women with osteoporosis. Eur J Endocrinol 2003;149:209-13.
16. Enrique CT. Osteoporosis: consideraciones diagnosticas y terapéuticas. Rev Med Hered 2004;15:101-7.
17. Bonnick SL, Shulman L. Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both? Am J Med 2006;119(4 Suppl 1):S25-31.
18. Kim SW, Park DJ, Park KS, Kim SY, Cho BY, Lee HK, et al. Early changes in biochemical markers of bone turnover predict bone mineral density response to antiresorptive therapy in Korean postmenopausal women with osteoporosis. Endocr J 2005;52: 667-74.
19. Tiselius HG; Advisory Board of European Urolithiasis Research and EAU Health Care Office Working Party for Lithiasis. Possibilities for preventing recurrent calcium stone formation: principles for the metabolic evaluation of patients with calcium stone disease. BJU Int 2001;88:158-68.
20. Arrabal-Martin M, Fernandez-Rodriguez A, Arrabal-Polo MA, Garcia-Ruiz MJ, Zuluaga-Gomez A. Extracorporeal renal lithotripsy: evolution of residual lithiasis treated with thiazides. Urology 2006;68:956-9.
21. Legroux-Gerot I, Catanzariti L, Marchandise X, Duquesnoy B, Cortet B. Bone mineral density changes in hypercalciuretic osteoporotic men treated with thiazide diuretics. Joint Bone Spine 2004;71:51-5.
22. Arrabal Martin M, Diaz de la Guardia FV, Jimenez Pacheco A, Lopez Leon V, Arrabal Polo MA, Zuluaga Gomez A. The treatment of renal lithiasis with biphosphonates. Arch Esp Urol 2007;60: 745-54.
23. Giusti A, Barone A, Pioli G, Girasole G, Siccardi V, Palummeri E, et al. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments. Nephrol Dial Transplant 2009;24:1472-7.